Angioimmunoblastic Lymphadenopathy With Dysproteinemia - 244 Studies Found
Completed |
: Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma :
|
Terminated |
: 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma :
|
Completed |
: Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma :
|
Recruiting |
: A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL) :
: Drug: Brentuximab vedotin study drug given intravenously to determine efficacy in study diseases |
Completed |
: 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma :
|
Completed |
: Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma :
|
Completed |
: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas :
|
Completed |
: 506U78 in Treating Patients With Lymphoma :
|
Recruiting |
: Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma :
: |
Recruiting |
: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency :
|